Arthroscopic chondroplasty is a knee arthroscopy procedure for the
repairing of mild to moderately damaged cartilage in the knee. It is
minimally invasive outpatient procedure in which the damaged and
loosened parts of the cartilage is excised using an arthroscope and
small incision instruments. Articular cartilage is a smooth tissue
lining covering the surfaces of the two bones in a knee joint. The
major function of the cartilage is to reduce friction and provide a
smooth surface for the two bones to glide over each other smoothly
during movement. Cartilage also provide cushioning to the bones and
acts as a shock absorber for the joint during rigorous activities
like jumping and running.
Since the cartilage do not have any direct blood supply, factors like
pressure activities, trauma, diseases or age can sometime lead to
wear and tear of the cartilage. Severe damage to the cartilage can
cause swelling, pain, popping and locking of the joint, and can lead
to osteoarthritis. Chondroplasty is the procedure to repair this
damaged cartilage. In arthroscopic chondroplasty, a small incision is
made in the knee and the damaged cartilage is inspected using a small
surgical camera called arthroscope which allows the surgeons to
clearly view surgical site without making large cuts or incisions in
the knee. The damaged part of the cartilage are then removed using
special tools and cartilage surface is smoothened using surgical
ablation devices. Healthy cartilage then grows to replace the damaged
parts.
The global arthroscopic chondroplasty market is expected to grow at a
swift speed due to a number of factors. The steep rise in the number
of trauma cases, industrial accidents, and sport-related injuries is
one of the major factors driving the global arthroscopic
chondroplasty market. With the increasing consciousness about the
importance of physical activity for a healthy lifestyle, the number
of sport related injuries is also increasing exponentially across the
globe. According to the ‘National Health Statistics Reports’
published in November 2016, by the Center for Disease Control and
Prevention (CDC) titled ‘Sports and Recreation-related Injury
Episodes in the United States, 2011–2014’, an estimated 8.6
million such injuries are reported annually in the US. Increasing
prevalence of obesity is also driving the global arthroscopic
chondroplasty market.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36974
Growth in the global geriatric population susceptible to joint
problems is also expected to drive the market during the forecast
period. A report published by the Population Division of the
Department of Economic and Social Affairs of the United Nations (UN)
in 2013 stated that, the number of elderly persons (aged 60 years or
over) is estimated to more than double, from 841 million in 2013 to
over 2 billion in 2050. Technological advancements and convenience of
being a minimally invasive procedure is also expected to increase the
demand for arthroscopic chondroplasty during the forecast period.
However, poor or absence of proper reimbursement for innovative
technologies, particularly in developing countries, can negatively
affect the growth of the market.
In terms of geography, the arthroscopic chondroplasty market can be
segmented into North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. North America and Europe are projected
to remain the dominant markets for arthroscopic chondroplasty due to
the high spending on healthcare, increase in the orthopedic
procedures, growth in prevalence of obesity, and introduction of
technologically advanced products in the region. Asia Pacific is
expected to expand at a high CAGR owing to the rising demand for
arthroscopic chondroplasty in developing nations.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=36974<ype=S
Key players operating in the arthroscopic chondroplasty market
include B. Braun Melsungen AGDePuy Synthes (J&J), NuOrtho
Surgical, Inc., Smith & Nephew plc, Stryker Corporation, Zimmer
Biomet Holdings, Inc., Osiris Therapeutics, Inc., ISTO Technologies,
Inc., and Sklar Surgical Instruments.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment